Genexine, Inc. (KOSDAQ:095700)
South Korea · Delayed Price · Currency is KRW 6,160.00
+480.00 (8.45%)
Oct 10, 2025, 3:30 PM KST
Genexine Market Cap
Genexine has a market cap or net worth of 280.15 billion as of October 10, 2025. Its market cap has increased by 7.80% in one year.
Market Cap
280.15B
Enterprise Value
296.32B
Revenue
5.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,160.00
Market Cap Chart
Since September 15, 2009, Genexine's market cap has increased from 109.02B to 280.15B, an increase of 156.98%. That is a compound annual growth rate of 6.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 280.15B | 15.36% |
| Dec 30, 2024 | 242.86B | -40.82% |
| Dec 28, 2023 | 410.35B | -12.73% |
| Dec 29, 2022 | 470.21B | -67.78% |
| Dec 30, 2021 | 1,459.20B | -52.47% |
| Dec 30, 2020 | 3,069.93B | 106.72% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |